Similar to previous reports (Dymalla et al., 2009; Celegato et al., 2020), treatment with ZHPV16E61235 significantly elevated the expression of p53 in HPV16-positive cancer cells compared with treatment with ZWT. Here, TP53 is linked to cancer.